Podcasts and Webinars
Digital Twins for Clinical Trials with Charles Fisher from Unlearn AI
Builders #31 w/ Charles Fisher - Founder & CEO @ Unlearn.AI | BIOS
Mendel at SXSW - Clinical AI Is Not Just Any AI
How will AI transform the future of medicine?
Reimagining clinical trials with Charles Fisher
The catastrophe of traditional statistical learning
Founding Unlearn and Revolutionizing Clinical Trials with Charles Fisher
How do digital twins of patients improve clinical trials?
Uber earnings + using AI to revolutionize clinical trials w/ Unlearn.AI’s Charles Fisher | E1734
Using external data to accelerate randomized controlled trials without introducing bias
AI for improving clinical trials & drug development, entrepreneurship & AI safety | Charles Fisher
AI in Action E380: Charles Fisher, CEO at unlearn.ai
Why can’t we agree on how to define digital twins in healthcare?
Applying machine learning to increase trial efficiency: a regulatory journey
Innovation in Clinical Research: AI-Based Drug Development Tools and The Regulatory Landscape
Faster, More Efficient Trials: Novel Trial Designs Using Digital Twins
AI, Digital Twins, and the Future of Clinical Research
Using AI & Digital Twins in Clinical Trials | Charles Fisher CEO, Unlearn
MedCity INVEST Digital Health: The Role of Digital Twins in Life Sciences
AI in Action 206: Charles Fisher, Founder & CEO at Unlearn.ai
#052 Digital Twins in Clinical Trials — Dr Charles Fisher (CEO Unlearn.ai)
Neuroscience and Artificial Intelligence Webinar
#014: Diversity in Digital Health and How Primary Care Will Cope with the Vaccine
Recruit Rockstars 367: How His VC-Backed Team Made Drug Development Faster
CHARLES FISHER ON USING DIGITAL TWINS TO SPEED CLINICAL TRIALS
Charles Fisher- Using Digital Twins to Speed Clinical Trials
Episode 27 – Using Artificial Intelligence to speed Alzheimer’s studies
#7 Unlearn.AI: Charles Fisher on reimaging clinical trials with AI
#111: The Story of Unlearn.ai with Charles Fisher
Bloomberg Radio: Using AI Digital Twins for Drug Testing (Podcast)
Press
How digital twins could support more affordable Alzheimer’s research
Would you take a drug created with AI?
FDA grapples with its role in AI, and how to guide industry's adoption
The AI-Generated Population Is Here, and They’re Ready to Work
As AI proliferates in pharma, regulators look to catch up in clinical trials
Unlearn CEO: Digital twins could slash clinical trial patient enrollment by 25% or more
Charles Fisher, Ph.D., CEO & Founder of Unlearn – Interview Series
AI 100: The Artificial Intelligence Startups Redefining Industries
Life sciences use of digital twins mirrors its application in other industries
Meet Your Digital Twin: The Coming Revolution In Drug Development
A New Generation Invents Pharma’s Mirrored Future
AI Trends In 2022: What’s Real And What’s Hype? Hear From The Experts
Will digital clones transform how pharmas run clinical trials? This S.F. startup is counting on it